• Users Online: 173
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2019  |  Volume : 5  |  Issue : 2  |  Page : 118-125

To evaluate and quantify the Rifampicin Sensitive/Resistant tuberculosis using Xpert MTB/RIF Assay : Our Experience at the DOTS plus site


1 Additional Professor, Dept. of TB & Chest, IGIMS, Patna, Bihar, India
2 Associate Professor, Dept. of TB & Chest, IGIMS, Patna, Bihar, India
3 Assistant Professor, Dept. of Pneumnology, IGIMS, Patna, Bihar, India
4 Associate Professor, Dept. of Microbiology, IGIMS, Patna, Bihar, India
5 Associate Professor, Dept. of Community Medicine, IGIMS, Patna, Bihar, India

Correspondence Address:
Satyadeo Choubey
Associate Professor, Dept. of TB & Chest IGIMS
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Context: Cartridge based nucleic acid amplification test (CBNAAT) is a diagnostic tool which detects both Mycobacterium tuberculosis and its resistance to Rifampicin. Bihar has a high burden of tuberculosis but the data regarding the total and multidrug resistant TB (MDR-TB) burden is lacking. Aims: To quantify the burden of TB and Rifampicin resistance presenting in a DOTS plus site hospital of Bihar using CBNAAT. Setfngs and Design: A hospital based cross sectional study. Methods and Material: All the suspected patients coming to the department of TB & chest at our institute were made to deposit there site specific samples for CBNAAT. The test result (detected/not detected, Rifampicin sensitive/ resistant) were fed into Microsoft Excel and analysis was done using Epi-info statistical software. Statistical analysis used: Descriptive statistic was used. Results: Out of 4096 suspected patients, 958 were positive by CBNAAT between February 2016 to November 2017. 772 cases (80.58%) were sensitive while 186 (19.41%) were resistant to Rifampicin. It was pulmonary TB in 710 patients and extra pulmonary TB (EPTB) in 248 patients. Among males, 539 (20.4%) were sensitive while 124(4.7%) were resistant to Rifampicin and 233 (16.1%) and 62 (4.3%) respectively in females. 16-35 age group had the highest TB burden. Patna district has the highest TB burden. Conclusions: Bihar harbors a significant burden of TB patients including the drug resistant cases. Utmost attention of TB control programme and prompt treatment is need of the hour.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1206    
    Printed60    
    Emailed0    
    PDF Downloaded76    
    Comments [Add]    

Recommend this journal